Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Unicycive Therapeutics Inc
UNCY
Healthcare
Biotechnology
Unicycive Therapeutics, Inc. is a biotechnology company that is developing treatments for certain medical conditions. Its programs are focused on kidney disease, an area that has the potential to offer medical benefits. Its development programs are focused on two novel therapies: Oxylanthanum Carbonate, and UNI 494. Oxylanthanum Carbonate is a novel investigational phosphate binding agent being...
developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. UNI-494 is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury. Oxylanthanum Carbonate and UNI 494 were initially developed by and licensed to it from Spectrum Pharmaceuticals (Spectrum) and Sphaera Pharma, respectively.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:UNCY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 2:29pm
UNCY.....dodged a bullet there ; )
UNCY halted on the way down....seldom a "good thing" GLTA
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 2:18pm
UNCY ...... I'd say it will go higher ; )
I sold mine I like leaving some profit for the next guy Cheers !
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 2:17pm
UNCY...Breaks $1.43 on that pop
With a volume spike Sold ; )
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 1:54pm
UNCY....meh
fuggetabouttit
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 1:53pm
UNCY ..... trading above VWAP at $1.33...
needs a volume spike and a break of $1.43 No position
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 1:44pm
UNCY ....bounced off low
A break of $1.43 is needed to get me into this
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 11:44am
UNCY......just as forecasted....support broken
Now $1.14....has to go now or next pivot is $1.00 ....then $0.85 Me ...no position
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 10:51am
UNCY.....better get a rally or it's done
$1.27
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 10:22am
UNCY....early a.m runner on NR
In PB mode No position
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 29, 2022 1:24pm
UNCY ....needs to bust thru 61 resisitance
If it does,,,,watch out world ; )
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 29, 2022 12:09pm
UNCY...... Good idea !!!!!!!!!!!!!!
Unicycive Announces Termination of ¢ € At-The-Market ¢ € Offering of Shares of Common Stock 2022-12-29 08:31 ET - News Release LOS ALTOS, Calif., Dec. 29, 2022 (GLOBE
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >